A trio of studies published this week in the New England Journal of Medicine showed that devices from Abbott (NYSE:ABT) and W.L. Gore & Assoc. designed to close a heart defect lowered the risk of a recurring episode in certain cryptogenic stroke patients. Long-term results from the 980-patient Respect trial of the Amplatzer device Abbott acquired […]
Structural heart
St. Jude Medical launches pediatric trial for Amplatzer Duct Occluder II AS cardiac implant
St. Jude Medical (NYSE:STJ) said today that it’s launching a pediatric clinical trial of a version of its Amplatzer cardiac implant for treating a congenital heart defect. The 50-patient ADO II AS study is designed to enroll 2 patient cohorts: at least 15 patients weighing 4.4 lbs. (2kg) or less and at least 25 patients weighing more […]